This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Sandbox 7722

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (06:13, 5 June 2018) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
==Your Heading Here (maybe something like 'Structure')==
==Your Heading Here (maybe something like 'Structure')==
-
<StructureSection load='1acj' size='340' side='right' caption='AChE_with_Tacrine''>
+
<StructureSection load='3PBB' size='340' side='right' caption='Glutaminyl_Cyclase_with_PBD150''>
-
<scene name='78/789344/Tacrine_in_ache/2'>Tacrine</scene> was the first anti cholinesterase FDA approved drug for treating Alzheimer's Disease. It binds between <scene name='78/789344/Tacrine_in_ache/3'>W84 and F330</scene> (near the active site) to inhibit the enzyme.
+
Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer’s disease (AD).
== Function ==
== Function ==

Current revision

Your Heading Here (maybe something like 'Structure')

PDB ID 3PBB

Drag the structure with the mouse to rotate

References

Personal tools